| Literature DB >> 25525604 |
Shijun Wang1, Karen Burtt1, Baris Turkbey2, Peter Choyke2, Ronald M Summers1.
Abstract
Prostate cancer (PCa) is the most commonly diagnosed cancer among men in the United States. In this paper, we survey computer aided-diagnosis (CADx) systems that use multiparametric magnetic resonance imaging (MP-MRI) for detection and diagnosis of prostate cancer. We review and list mainstream techniques that are commonly utilized in image segmentation, registration, feature extraction, and classification. The performances of 15 state-of-the-art prostate CADx systems are compared through the area under their receiver operating characteristic curves (AUC). Challenges and potential directions to further the research of prostate CADx are discussed in this paper. Further improvements should be investigated to make prostate CADx systems useful in clinical practice.Entities:
Mesh:
Year: 2014 PMID: 25525604 PMCID: PMC4267002 DOI: 10.1155/2014/789561
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Workflow of a typical prostate CADx system. Green rectangles indicate data (original scans and images after preprocessing); yellow rectangles indicate processes applied to the data or images.
Figure 2Illustration of a prostate CAD prediction map showing true positive cancer classified correctly by SVM. The red rectangle indicates an image patch within the cancer in which local image features are extracted from T2WI, ADC, and Ktrans map. The green contour denotes the boundary of the prostate. Bright regions in the CAD prediction map correspond to a high probability of cancer and coincide with the correct location of the cancer.
Performance comparison of major prostate CADx systems published.
| Publication | Data size | Modality | Field strength | Ground truth | Candidate generation | Region | Classifier | Performance |
|---|---|---|---|---|---|---|---|---|
| Chan et al. 2003 [ | 15 | T2WI, ADC, PD, and T2 map | 1.5T | MSTR + biopsy | RS + cancer | PZ | FLD | AUC = 0.839 (±0.064) |
| Puech et al. 2009 [ | 100 | DCE | 1.5T | Biopsy + RS | Manual ROI | WP | Rule-based | AUC = 0.77 |
| Vos et al. 2008 [ | 34 | DCE | 1.5T | Biopsy | Manual ROI | PZ | SVM | AUC = 0.83, CI [0.75, 0.92] |
| Vos et al. 2010 [ | 34 | T2WI, DCE | 1.5T | Biopsy | Manual ROI | PZ | SVM | AUC = 0.89, CI [0.81, 0.95] |
| Shah et al. 2012 [ | 31 | T2WI, ADC, and DCE | 3T | Biopsy | Manual ROI | PZ | SVM |
|
| Liu and Yetik 2011 [ | 20 | T2WI, ADC, and DCE | 1.5T | Biopsy | Voxel | WP | SVM | AUC = 0.89 |
|
Liu et al. 2013 [ | 54 | T2WI, ADC, and DCE | 3T | Biopsy | Biopsy spots | WP | SVM | AUC = 0.82, CI [0.71, 0.93] |
|
Niaf et al. 2012 [ | 30 | T2WI, ADC, and DCE | 1.5T | MSTR + biopsy | Manual ROI | PZ | SVM | AUC = 0.89, CI [0.81, 0.94] |
| Moradi et al. 2012 [ | 29 | DT, DCE | 3T | Biopsy | Biopsy spots | WP | SVM | AUC = 0.96 |
| Niaf et al. 2014 [ | 49 | T2WI, ADC, and DCE | Not specified | MSTR + biopsy | Manual ROI | WP | P-SVM | AUC = 0.889 |
| Peng et al. 2013 [ | 48 | T2WI, ADC, and DCE | 3T | MSTR + biopsy | Manual ROI | WP | LDA | AUC = 0.95 (±0.02) |
| Artan et al. 2010 [ | 21 | T2WI, ADC, and DCE | 1.5T | Biopsy | Voxel | PZ | CRF | AUC = 0.79 (±0.12) |
| Tiwari et al. 2013 [ | 29 | T2WI, MRS | 1.5T | MSTR + biopsy | Voxel | WP | SeSMiK-GE + random forest | AUC = 0.89 (±0.09) |
| Tiwari et al. 2012 [ | 36 | T2WI, MRS | 1.5T | MSTR + biopsy | Voxel | WP | Random forest | AUC = 0.89 (±0.02) |
| Litjens et al. 2014 [ | 347 | T2WI, PDWI, DCE, and DWI | 3T | Biopsy | Voxel | WP | Random forest | AUC = 0.889 |
PD: proton density; MSTR: manual segmented tumor by radiologist; RS: random sampling; AUC: area under the ROC curve; HMM: hidden Markov models; WP: whole prostate; CI: confidence interval; ROI: region of interest; RG: region growing; FSE: fast spin-echo; DT: diffusion tensor; P-SVM: probabilistic SVM; SeSMiK-GE: semisupervised multikernel graph-embedded, PDWI: proton density-weighted imaging.